– Showcases Allplex™ HPV merchandise designed to check for 14 high-risk HPV genotypes
– Advocates HPV testing for early analysis and prevention of cervical most cancers
– Goals to speed up the widespread adoption of syndromic PCR testing to create “a world free from all illnesses”
SEOUL, South Korea, July 16, 2024 /PRNewswire/ — Seegene Inc. (KQ096530), a number one South Korean firm offering a complete resolution for PCR molecular diagnostics, demonstrated its human papillomavirus (HPV) diagnostic merchandise and underscored the crucial significance of HPV screening check on the Asia-Oceania Analysis Group in Genital An infection and Neoplasia (AOGIN) convention, held in Seoul, South Korea from July 11-13.
On the AOGIN, Seegene introduced its superior applied sciences for figuring out viruses linked to cervical most cancers. The corporate organized an exhibition sales space and hosted a symposium session underneath the theme of ‘Navigating medical tips and implementations for HPV cervical most cancers screening.’
The corporate showcased its distinctive quantitative PCR technology-based HPV diagnostic merchandise, ‘Allplex™ HPV HR Detection’ and ‘Allplex™ HPV28 Detection’. The Allplex™ HPV HR Detection is designed to check for 14 high-risk HPVs, together with sorts 16 and 18, in a single tube. The Allplex™ HPV28 Detection is designed to check for 28 HPVs, in two tubes, together with 19 high-risk sorts and 9 low-risk sorts, in two tubes. The merchandise are perfect for cervical most cancers prevention and follow-up administration.
The corporate additionally launched Seegene’s STARlet-AIOS™, a completely automated molecular diagnostic testing system that streamlines the complete PCR course of from nucleic acid extraction to outcome evaluation, together with SG STATS, the corporate’s premium platform of superior statistical evaluation.
On the symposium session hosted by Seegene on July 11, Dr. Lan Xu from the Shanghai Jiao Tong College of Public Well being in China introduced a lecture on “Medical validation of human papillomavirus assays for cervical most cancers screening by way of the VALGENT framework.” Dr. Shin-Wha Lee from the Asan Medical Heart and College of Ulsan in Korea confirmed her research on “Incorporating HPV testing with genotypes in population-based screening packages.”
“At AOGIN, we have been capable of showcase the excellence of Seegene’s PCR testing expertise and HPV merchandise. We count on our HPV merchandise to be adopted in cervical most cancers screening packages in additional international locations,” mentioned Daniel Shin, Government Vice-President and Chief International Gross sales and Advertising Officer at Seegene. “We’re at present working a marketing campaign within the international market to lift consciousness about the advantages of syndromic PCR testing, together with simultaneous testing for HPV and sexually transmitted infections (STIs). We imagine the marketing campaign will pave the best way for the widespread adoption of syndromic PCR testing, serving to to understand “a world free from all illnesses.”
Seegene’s syndromic quantitative PCR expertise is simultaneous multiplex molecular diagnostic expertise based mostly on real-time PCR. It permits for the detection of varied pathogens inflicting comparable signs in a single tube, facilitating quick and correct analysis. Moreover, analyzing the cycle threshold (Ct) worth helps decide the extent of the an infection, which boosts medical follow. Seegene is the primary to globally commercialize ‘3 Ct’ expertise, which may present the Ct worth of three targets in a single channel.
Cervical most cancers is the fourth commonest most cancers amongst girls worldwide, with the second-highest mortality price. In line with the World Well being Group (WHO), roughly 600,000 girls are newly identified with cervical most cancers every year globally, leading to 340,000 deaths. Within the Asia-Pacific area alone, about 270,000 girls are identified yearly, with over 140,000 deaths reported. The WHO has set a goal to attain 70% cervical most cancers screening protection by 2030, a major enhance from the present 20%. In 2020, solely 33% of ladies had been screened for cervical most cancers not less than as soon as.
There are about 200 HPV genotypes, of which 99.8% of cervical cancers are brought on by HPV. Sorts 16 and 18 account for 70% of cervical most cancers, whereas 19 high-risk sorts are accountable for 90% of all most cancers instances. The development to most cancers depends upon the genotype of the HPV an infection, the extent of the an infection and co-infection. Since most HPV infections don’t current clear signs, correct detection is crucial for the early analysis of cervical most cancers. Not too long ago, many international locations have been recommending HPV testing as an alternative of the Pap smear for cervical most cancers screening.
About Seegene
Seegene has 23 years of devoted R&D, manufacturing, and enterprise expertise round syndromic quantitative PCR applied sciences, which was highlighted through the COVID-19 pandemic when it supplied over 340 million COVID-19 assessments to greater than 100 international locations worldwide. The core characteristic of Seegene’s distinctive syndromic PCR applied sciences is the power to concurrently check 14 pathogens that trigger comparable signs in a single tube and supply quantitative data on the infectivity profile to correlate with the severity of sickness.
About AOGIN 2024
The AOGIN, based in 2004, contains of 25 member international locations in Asia and Oceania. The group hosts worldwide tutorial conferences targeted on the therapy and prevention of cervical most cancers. This 12 months’s convention in Seoul attracted over 500 consultants from 22 international locations, together with China, Japan, and India, who shared the most recent analysis findings and medical practices relating to HPV.
Brand – https://mma.prnewswire.com/media/1357790/Seegene_logo_Logo.jpg
